EUR 0.23
(22.34%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 13.01 Million EUR | -2.85% |
2022 | 13.39 Million EUR | 459.66% |
2021 | 2.39 Million EUR | -41.38% |
2020 | 4.08 Million EUR | -61.44% |
2019 | 10.59 Million EUR | 4.91% |
2018 | 10.09 Million EUR | -1.96% |
2017 | 10.29 Million EUR | 12.77% |
2016 | 9.13 Million EUR | 7.44% |
2015 | 8.49 Million EUR | 54.25% |
2014 | 5.51 Million EUR | -18.33% |
2013 | 6.74 Million EUR | 132.77% |
2012 | 2.89 Million EUR | 32.55% |
2011 | 2.18 Million EUR | -16.97% |
2010 | 2.63 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 11.57 Million EUR | 0.0% |
2023 Q4 | 13.01 Million EUR | 0.0% |
2023 Q2 | 14.31 Million EUR | 0.0% |
2023 FY | 13.01 Million EUR | -2.85% |
2022 Q2 | 13.02 Million EUR | 0.0% |
2022 FY | 13.39 Million EUR | 459.66% |
2022 Q4 | 13.39 Million EUR | 0.0% |
2021 FY | 2.39 Million EUR | -41.38% |
2021 Q4 | 2.39 Million EUR | 0.0% |
2021 Q2 | 13.06 Million EUR | 0.0% |
2020 FY | 4.08 Million EUR | -61.44% |
2020 Q4 | 4.08 Million EUR | 0.0% |
2020 Q2 | 12.5 Million EUR | 0.0% |
2019 Q4 | 10.59 Million EUR | 0.0% |
2019 Q2 | 10.41 Million EUR | 0.0% |
2019 FY | 10.59 Million EUR | 4.91% |
2018 Q2 | 10.1 Million EUR | 0.0% |
2018 Q4 | 10.09 Million EUR | 0.0% |
2018 FY | 10.09 Million EUR | -1.96% |
2017 Q2 | 8.36 Million EUR | 0.0% |
2017 FY | 10.29 Million EUR | 12.77% |
2017 Q4 | 10.29 Million EUR | 0.0% |
2016 Q4 | 9.13 Million EUR | 0.0% |
2016 Q2 | 8.87 Million EUR | 0.0% |
2016 FY | 9.13 Million EUR | 7.44% |
2015 FY | 8.49 Million EUR | 54.25% |
2015 Q4 | 8.49 Million EUR | 0.0% |
2015 Q2 | 5.92 Million EUR | 0.0% |
2014 FY | 5.51 Million EUR | -18.33% |
2014 Q2 | 6.04 Million EUR | 0.0% |
2014 Q4 | 5.51 Million EUR | 0.0% |
2013 FY | 6.74 Million EUR | 132.77% |
2013 Q4 | 6.74 Million EUR | 0.0% |
2012 FY | 2.89 Million EUR | 32.55% |
2011 FY | 2.18 Million EUR | -16.97% |
2010 FY | 2.63 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Affluent Medical SA | 25.15 Million EUR | 48.246% |
Bluelinea Société Anonyme | 8.86 Million EUR | -46.836% |
Carmat SA | 96.83 Million EUR | 86.557% |
Diagnostic Medical Systems S.A. | 37.41 Million EUR | 65.211% |
Euromedis Groupe | 23.66 Million EUR | 45.001% |
Eurobio Scientific Société anonyme | 141.15 Million EUR | 90.779% |
Ikonisys S.A. | 5.11 Million EUR | -154.232% |
Implanet S.A. | 10.81 Million EUR | -20.401% |
Median Technologies SA | 46.22 Million EUR | 71.843% |
SpineGuard SA | 5 Million EUR | -160.154% |
Euroapi S.A. | 684.7 Million EUR | 98.099% |
Guerbet SA | 646.97 Million EUR | 97.988% |